Skip to main content
NIH funding notice PAR-21-109

Early Stage Investigator Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)

Closed on May 7, 2024.

Posted
January 11, 2021
Close date
May 7, 2024
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $3,837,076 in first-year total cost, median $353,000.

Most frequent study sections

  1. Vaccines Against Microbial Diseases Study Section[VMD]2
  2. Cellular Mechanisms in Aging and Development Study Section[CMAD]1
  3. Chronic Dysfunction and Integrative Neurodegeneration Study Section[CDIN]1
  4. Emerging Imaging Technologies in Neuroscience Study Section[EITN]1
  5. HIV Immunopathogenesis and Vaccine Development Study Section[HIVD]1

Most frequent institutions

  1. TEXAS BIOMEDICAL RESEARCH INSTITUTE2
  2. UNIVERSITY OF WASHINGTON2
  3. BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
  4. KENT STATE UNIVERSITY1
  5. NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
Competing awards under PAR-21-109 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2024Connecting across Scales: Integration of Cell-Specific Microstructure within Long-Range Brain Networks in the Macaque Monkey1R21AG083539-01A1RAVEN, ERIKA PRATTNEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$689,525EITN
2023Malaria vaccine evaluation in a novel infant NHP challenge model1R21AI168739-01A1SHEARS, MELANIE JANETUNIVERSITY OF WASHINGTON, WA$353,000VMD
2023SARS-CoV-2 vaccine durability during SIV infection1R21AI170094-01A1O'CONNOR, MEGAN AUNIVERSITY OF WASHINGTON, WA$353,000HIVD
2023Use of a non-human primate model to define the role of T cell immune responses in persistent Kaposi sarcoma-associated herpesvirus infection and Kaposi sarcoma pathogenesis1R21AI168750-01A1MUTSVUNGUMA, LORRAINE ZVICHAPERABECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA$345,516VIRB
2023Mesenchymal stem/stromal cells to enhance cytotoxic T cell immunity during HIV infection1R21OD032351-01A1KOL, AMIRUNIVERSITY OF CALIFORNIA AT DAVIS, CA$319,417IHD
2023The effect of aging on neurotransmitters and motor performance in a primate model1R21AG080216-01EDLER, MELISSA K.KENT STATE UNIVERSITY, OH$315,381CDIN
2022Single cell trancriptomics to identify LTBI reactivation markers in TB/HIV co-infection1R21AI170148-01SHARAN, RITITEXAS BIOMEDICAL RESEARCH INSTITUTE, TX$412,506ZRG1
2022Pigtail Macaque Model of Human-Simian Immunodeficiency Virus Infection1R21AI165289-01A1THIPPESHAPPA, RAJESHTEXAS BIOMEDICAL RESEARCH INSTITUTE, TX$378,000HVCD
2022Group A Streptococcus Vaccination to prevent Strep throat in an NHP model1R21AI171385-01DAN, JENNIFER MARIEUNIVERSITY OF CALIFORNIA, SAN DIEGO, CA$353,731VMD
2022Early life effects on later life health and aging: molecular mechanisms and context-dependency1R21AG078554-01LEA, AMANDAVANDERBILT UNIVERSITY, TN$317,000CMAD

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.